Literature DB >> 8778531

The effect of disease-prevalence adjustments on the accuracy of a logistic prediction model.

A P Morise1, G A Diamond, R Detrano, M Bobbio, E Gunel.   

Abstract

The accuracy of a logistic prediction model is degraded when it is transported to populations with outcome prevalences different from that of the population used to derive the model. The resultant errors can have major clinical implications. Accordingly, the authors developed a logistic prediction model with respect to the noninvasive diagnosis of coronary disease based on 1,824 patients who underwent exercise testing and coronary angiography, varied the prevalence of disease in various "test" populations by random sampling of the original "derivation" population, and determined the accuracy of the logistic prediction model before and after the application of a mathematical algorithm designed to adjust only for these differences in prevalence. The accuracy of each prediction model was quantified in terms of receiver operating characteristic (ROC) curve area (discrimination) and chi-square goodness-of-fit (calibration). As the prevalence of the test population diverged from the prevalence of the derivation population, discrimination improved (ROC-curve areas increased from 0.82 +/- 0.02 to 0.87 +/- 0.03; p < 0.05), and calibration deteriorated (chi-square goodness-of-fit statistics increased from 9 to 154; p < 0.05). Following adjustment of the logistic intercept for differences in prevalence, discrimination was unchanged and calibration improved (maximum chi-square goodness-of-fit fell from 154 to 16). When the adjusted algorithm was applied to three geographically remote populations with prevalences that differed from that of the derivation population, calibration improved 87%, while discrimination fell by 1%. Thus, prevalence differences produce statistically significant and potentially clinically important errors in the accuracy of logistic prediction models. These errors can potentially be mitigated by use of a relatively simple mathematical correction algorithm.

Entities:  

Mesh:

Year:  1996        PMID: 8778531     DOI: 10.1177/0272989X9601600205

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  7 in total

1.  Simple optimal weighting of cases and controls in case-control studies.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008-09-29       Impact factor: 0.968

2.  A risk score for the prediction of advanced age-related macular degeneration: development and validation in 2 prospective cohorts.

Authors:  Chung-Jung Chiu; Paul Mitchell; Ronald Klein; Barbara E Klein; Min-Lee Chang; Gary Gensler; Allen Taylor
Journal:  Ophthalmology       Date:  2014-03-18       Impact factor: 12.079

3.  A clinical score to reduce unnecessary antibiotic use in patients with sore throat.

Authors:  W J McIsaac; D White; D Tannenbaum; D E Low
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

4.  What percent luminal stenosis should be used to define angiographic coronary artery disease for noninvasive test evaluation?

Authors:  Michael Lipinski; Dat Do; Anthony Morise; Victor Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-04       Impact factor: 1.468

5.  The validity of a sore throat score in family practice.

Authors:  W J McIsaac; V Goel; T To; D E Low
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

6.  External Validation of the Modified 4C Deterioration Model and 4C Mortality Score for COVID-19 Patients in a Swiss Tertiary Hospital.

Authors:  Adriana Wirth; Andrea Goetschi; Ulrike Held; Ataman Sendoel; Melina Stuessi-Helbling; Lars Christian Huber
Journal:  Diagnostics (Basel)       Date:  2022-05-03

7.  Beyond discrimination: A comparison of calibration methods and clinical usefulness of predictive models of readmission risk.

Authors:  Colin G Walsh; Kavya Sharman; George Hripcsak
Journal:  J Biomed Inform       Date:  2017-10-24       Impact factor: 6.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.